Garrison Bradford & Associates’s Bristol-Myers Squibb BMY Stock Holding History

Garrison Bradford & Associates’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,000	Closed	-$241K	–	57
2020 Q3	$241K	Hold	4,000	–	–	0.34%	40
2020 Q2	$235K	Hold	4,000	–	–	0.34%	42
2020 Q1	$223K	Hold	4,000	–	–	0.38%	39
2019 Q4	$257K	Hold	4,000	–	–	0.32%	42
2019 Q3	$203K	Buy	+4,000	New	+$188K	0.28%	47
2019 Q1	–	Sell	-4,000	Closed	-$208K	–	83
2018 Q4	$208K	Hold	4,000	–	–	0.19%	65
2018 Q3	$248K	Hold	4,000	–	–	0.2%	59
2018 Q2	$221K	Hold	4,000	–	–	0.18%	63
2018 Q1	$253K	Hold	4,000	–	–	0.22%	57
2017 Q4	$245K	Hold	4,000	–	–	0.2%	63
2017 Q3	$255K	Hold	4,000	–	–	0.21%	62
2017 Q2	$223K	Hold	4,000	–	–	0.19%	64
2017 Q1	$218K	Hold	4,000	–	–	0.19%	66
2016 Q4	$234K	Hold	4,000	–	–	0.22%	61
2016 Q3	$216K	Hold	4,000	–	–	0.2%	67
2016 Q2	$294K	Hold	4,000	–	–	0.29%	55
2016 Q1	$256K	Hold	4,000	–	–	0.3%	53
2015 Q4	$275K	Hold	4,000	–	–	0.31%	56
2015 Q3	$237K	Hold	4,000	–	–	0.26%	66
2015 Q2	$266K	Hold	4,000	–	–	0.26%	69
2015 Q1	$258K	Hold	4,000	–	–	0.24%	74
2014 Q4	$236K	Hold	4,000	–	–	0.21%	81
2014 Q3	$205K	Buy	+4,000	New	+$200K	0.21%	88
2014 Q2	–	Sell	-4,000	Closed	-$208K	–	110
2014 Q1	$208K	Hold	4,000	–	–	0.2%	93
2013 Q4	$213K	Buy	+4,000	New	+$204K	0.2%	89

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Garrison Bradford & Associates's BMY Position: Q4 2020 in Review

Garrison Bradford & Associates sold out of Bristol-Myers Squibb (BMY) in Q4 2020, closing a stake of 4,000 shares — an estimated $241K sold.

Garrison Bradford & Associates first reported a position in BMY in Q4 2013 and held it in 25 quarters. The position peaked at $294K in Q2 2016. 2,360 funds tracked by Wall St. Rank hold BMY as of Q4 2020.

Garrison Bradford & Associates reported no remaining Bristol-Myers Squibb position as of Q4 2020 after selling out during the quarter.
Garrison Bradford & Associates sold 4,000 Bristol-Myers Squibb shares in Q4 2020, an estimated $241K.
Garrison Bradford & Associates first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 25 quarters.
Garrison Bradford & Associates's Bristol-Myers Squibb position peaked at $294K in Q2 2016.
2,360 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.

Based on Garrison Bradford & Associates's 13F filing for Q4 2020, filed 9 Feb 2021.